Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
Genetic Alterations during Colorectal-Tumor Development
1988 • 6,691 citations
Untangling the ErbB signalling network
2001 • 6,623 citations
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 • 4,480 citations
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
2004 • 1,810 citations
Receptor Protein-Tyrosine Kinases and Their Signal Transduction Pathways
1994 • 1,309 citations
A renaissance for SRC
2004 • 1,071 citations
Src family kinases in tumor progression and metastasis.
2003 • 787 citations
Protein kinase C isozymes and the regulation of diverse cell responses
2000 • 730 citations
ErbB Receptors: Directing Key Signaling Networks Throughout Life
2004 • 599 citations
Multiple pathways control protein kinase C phosphorylation
2000 • 598 citations
The ErbB receptors and their role in cancer progression
2003 • 590 citations
c-Src and cooperating partners in human cancer
2004 • 586 citations
The hunting of the Src
2001 • 584 citations
The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.
2003 • 361 citations
Overexpression of ErbB2 Blocks Taxol-Induced Apoptosis by Upregulation of p21Cip1, which Inhibits p34Cdc2 Kinase
1998 • 354 citations
PKC at a glance
2003 • 344 citations
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis
2002 • 339 citations
Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers
2004 • 308 citations
MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.
1995 • 269 citations
Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Cα
1996 • 175 citations
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
2004 • 142 citations
High PKC α and Low E-Cadherin Expression Contribute to High Migratory Activity of Colon Carcinoma Cells
2001 • 119 citations
Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma.
1991 • 117 citations
Roles of plakoglobin end domains in desmosome assembly
1997 • 114 citations
Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone
2003 • 110 citations
ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis
2005 • 107 citations
Protein Kinase C Alpha Expression in Breast and Ovarian Cancer
2004 • 95 citations
The link between PKCα regulation and cellular transformation
2004 • 64 citations
Regulation of Motility and Protease Expression in PKC-Mediated Induction of MCF-7 Breast Cancer Cell Invasiveness
1999 • 63 citations
Interaction of estrogen receptor α with protein kinase C α and c-Src in osteoblasts during differentiation
2003 • 46 citations
The future of cytotoxic therapy: selective cytotoxicity based on biology is the key
2003 • 46 citations
Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes in Vitro Colon Cancer Invasiveness
2004 • 35 citations
Inhibition of Protein Kinase Cα Enhances Anticancer Agent-Induced Loss of Anchorage-Independent Growth Regardless of Protection against Apoptosis by Bcl-2
2003 • 15 citations